Skip to Main Content
Back to News

Insider Sale: Chief Executive Officer of $PHR Sells 7,434 Shares

Automated

Chaim Indig, the Chief Executive Officer of $PHR, sold 7,434 shares of the company on 04-08-2025 for an estimated $174,377. We received data on the trade from a recent SEC filing. This was a sale of approximately 0.6% of their shares of this class of stock. Following this trade, they now own 1,262,398 shares of this class of $PHR stock.

$PHR Insider Trading Activity

$PHR insiders have traded $PHR stock on the open market 91 times in the past 6 months. Of those trades, 0 have been purchases and 91 have been sales.

Here’s a breakdown of recent trading of $PHR stock by insiders over the last 6 months:

  • EVAN ROBERTS (Chief Operating Officer) has made 0 purchases and 16 sales selling 95,486 shares for an estimated $2,552,473.
  • CHAIM INDIG (Chief Executive Officer) has made 0 purchases and 8 sales selling 71,561 shares for an estimated $1,892,464.
  • BALAJI GANDHI (Chief Financial Officer) has made 0 purchases and 13 sales selling 64,922 shares for an estimated $1,845,297.
  • DAVID LINETSKY (SVP, Life Sciences) has made 0 purchases and 16 sales selling 58,857 shares for an estimated $1,588,130.
  • ALLISON C HOFFMAN (General Counsel & Secretary) has made 0 purchases and 14 sales selling 52,203 shares for an estimated $1,374,850.
  • MICHAEL WEINTRAUB has made 0 purchases and 4 sales selling 55,152 shares for an estimated $1,321,348.
  • AMY BETH VANDUYN (SVP, Human Resources) has made 0 purchases and 9 sales selling 37,876 shares for an estimated $861,673.
  • YVONNE HUI (Principal Accounting Officer) has made 0 purchases and 11 sales selling 9,440 shares for an estimated $219,514.

To track insider transactions, check out Quiver Quantitative's insider trading dashboard.

$PHR Hedge Fund Activity

We have seen 90 institutional investors add shares of $PHR stock to their portfolio, and 89 decrease their positions in their most recent quarter.

Here are some of the largest recent moves:

To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.

$PHR Analyst Ratings

Wall Street analysts have issued reports on $PHR in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.

Here are some recent analyst ratings:

  • Citigroup issued a "Buy" rating on 01/10/2025
  • KeyBanc issued a "Overweight" rating on 01/08/2025

To track analyst ratings and price targets for $PHR, check out Quiver Quantitative's $PHR forecast page.

$PHR Price Targets

Multiple analysts have issued price targets for $PHR recently. We have seen 2 analysts offer price targets for $PHR in the last 6 months, with a median target of $31.0.

Here are some recent targets:

  • Joe Vruwink from Robert W. Baird set a target price of $30.0 on 12/11/2024
  • Gil Luria from D.A. Davidson set a target price of $32.0 on 11/29/2024

This article is not financial advice. See Quiver Quantitative's disclaimers for more information.

Add Quiver Quantitative to your Google News feed.Google News Logo

Suggested Articles